Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia

World Journal of Gastroenterology

Volumn 19, Issue 22, 2013, Pages 3502-3504

  Lal, Barun Kumar ^a   Stanley, Adrian ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Gastrooesophageal varices; Hypogammaglobilinaemia; Liver; Nodular regenerative hyperplasia; Portal hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HEMATEMESIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; LIVER BIOPSY; NODULAR HYPERPLASIA; PORTAL HYPERTENSION; STOMACH VARICES; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; UPPER GASTROINTESTINAL BLEEDING; VARICOSIS;

EID: 84879058022     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i22.3502     Document Type: Article

References (12)

1. Mahamid J, Miselevich I, Attias D, Laor R, Zuckerman E, Shaoul R. Nodular regenerative hyperplasia associated with idiopathic thrombocytopenic purpura in a young girl: a case report and review of the literature. J Pediatr Gastroenterol Nutr 2005; 41: 251-255
2. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12: 460-465 [DOI: 10.1097/00004836-19008000-00023]
3. Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, Kurumaya H, Harada A, Obata H. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996; 28: 195-204 [DOI: 10.1046/j.1365-2559.1996.d01-412.x]
4. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48 [DOI: 10.1006/clim.1999.4725]
5. Ward C, Lucas M, Piris J, Collier J, Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008; 153: 331-337 [DOI: 10.1111/j.1365-2249.2008.03711.x]
6. Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, Verkarre V, Bechade D, Poynard T, Hermine O, Cellier C. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008; 48: 74-82 [DOI: 10.1016/j.jhep.2007.08.011]
7. Rigaud S, Lopez-Granados E, Sibéril S, Gloire G, Lambert N, Lenoir C, Synaeve C, Stacey M, Fugger L, Stephan JL, Fischer A, Picard C, Durandy A, Chapel H, Latour S. Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG. Blood 2011; 118: 252-261 [DOI: 10.1182/blood-2011-01-328849]
8. Elariny HA, Mizrahi SS, Hayes DH, Boudreaux JP, Hussey JL, Farr GH. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation. Transpl Int 1994; 7: 309-313
9. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768 [DOI: 10.1016/j.jhep.2010.06.004]
10. Rajoriya N, Forrest EH, Gray J, Stuart RC, Carter RC, McKay CJ, Gaya DR, Morris AJ, Stanley AJ. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM 2011; 104: 41-47 [DOI: 10.1093/qjmed/hcq161]
11. Tripathi D, Ferguson JW, Therapondos G, Plevris JN, Hayes PC. Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther 2006; 24: 1-17 [DOI: 10.1111/j.1365-2036.2006.02965.x]
12. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12: 327-336